Neurology Minute
American Academy of Neurology
The Neurology Minute podcast delivers a brief daily summary of what you need to know in the field of neurology, the latest science focused on the brain, and timely topics explored by leading neurologists and neuroscientists. From the American Academy of Neurology and hosted by Stacey Clardy, MD, Ph.D., FAAN, with contributions by experts from the Neurology journals, Neurology Today, Continuum, and more.
Episodes
Mentioned books
Aug 3, 2023 • 4min
AAN President Elect Rost to Testify on New Alzheimer's Treatments
Dr. Natalia Rost discusses her testimony to Congress on New Alzheimer's Treatments. Show references: This episode was sponsored by the ExTINGUISH Trial for NMDAR Encephalitis: Call 844-4BRAIN5 to refer patients.
Aug 2, 2023 • 3min
When Myoclonus is Reversible
Dr. Kathryn Zuchowski discusses her NeuroByte, "When Myoclonus Is Reversible". Show references: https://learning.aan.com/diweb/catalog/item?id=11546015 This episode was sponsored by the ExTINGUISH Trial for NMDAR Encephalitis: Call 844-4BRAIN5 to refer patients.
Aug 1, 2023 • 5min
2024 Medicare Physician Fee Schedule Proposed Rule
Matt Kershner, Director, of Regulatory Affairs & Policy, at the American Academy of Neurology, discusses the 2024 Medicare Physician Fee Schedule Proposed Rule. Show references: https://www.aan.com/advocacy/capitol-hill-report This episode was sponsored by the ExTINGUISH Trial for NMDAR Encephalitis: Call 844-4BRAIN5 to refer patients.
Jul 31, 2023 • 3min
Pediatric Epilepsy Surgery
Dr. Adam Hartman discusses pediatric epilepsy surgery. Show references: https://www.thelancet.com/pdfs/journals/lanchi/PIIS2352-4642(23)00082-2.pdf https://pubmed.ncbi.nlm.nih.gov/37212692/ This episode was sponsored by the ExTINGUISH Trial for NMDAR Encephalitis: Call 844-4BRAIN5 to refer patients.
Jul 28, 2023 • 2min
Elamipretide for Mytochondrial Myopathy
Dr. Amel Karaa discusses the use of elamipretide in participants with genetically confirmed primary mitochondrial myopathies. Show references: https://n.neurology.org/content/101/3/e238
Jul 27, 2023 • 1min
Sarepta Announces FDA Approval of ELEVIDYS
Dr. Hoda Abdel-Hamid discusses the recent FDA approval for the first-ever gene therapy for Duchenne muscular dystrophy.
Jul 26, 2023 • 4min
Anti-Seizure Medication
Dr. Irfan Sheikh sheds light on the usage of anti-seizure medications within the inpatient setting.
Jul 25, 2023 • 2min
Cognitive Decline Following Heart Attack
Dr. Rae Bacharach discusses the Neurology Today article, "Cognitive Decline Appears to Speed Up in the Years Following a Heart Attack". Show references: https://journals.lww.com/neurotodayonline/fulltext/2023/07060/cognitive_decline_appears_to_speed_up_in_the_years.8.aspx
Jul 24, 2023 • 4min
Traumatic Brain Injury in Children
Dr. Halley Alexander discusses the paper, "It's Been a TRACK-TBI LONG Time Coming, but Well Worth the Wait". Show references: https://n.neurology.org/content/early/2023/06/21/WNL.0000000000207682
Jul 21, 2023 • 2min
New Treatment for IDH Mutant Gliomas
Dr. Ingo K. Mellinghoff discusses his paper, "Vorasidenib in IDH1- or IDH2-Mutant Low-Grade Glioma". Show references: https://pubmed.ncbi.nlm.nih.gov/37272516/
